Literature DB >> 23627255

Calcitonin measurement in aspiration needle washout fluids has higher sensitivity than cytology in detecting medullary thyroid cancer: a retrospective multicentre study.

Pierpaolo Trimboli1, Nadia Cremonini, Luca Ceriani, Enrico Saggiorato, Leo Guidobaldi, Francesco Romanelli, Claudio Ventura, Oriana Laurenti, Ilaria Messuti, Erica Solaroli, Raffaele Madaio, Massimo Bongiovanni, Fabio Orlandi, Anna Crescenzi, Stefano Valabrega, Luca Giovanella.   

Abstract

OBJECTIVE: Only few studies analysed the capability of cytology in detecting medullary thyroid cancer (MTC), and they reported a low accuracy of this diagnostic technique. Recently, calcitonin (CT) measurement in aspiration needle washout (FNA-CT) of thyroid and neck lesions has been reported as a sensitive tool for MTC. The aim of this study is to compare the sensitivity of FNA-CT and cytology in detecting MTC and to assess a cut-off value of FNA-CT for clinical practice. PATIENTS: Thirty-eight MTC lesions from 36 patients were retrospectively studied, diagnosed and treated in four different centres. Furthermore, 52 nonmedullary lesions from subjects undergone biopsy following increased serum CT were collected as a control group.
RESULTS: Cytology detected MTC in 21/37 lesions with 56·8% sensitivity. The median FNA-CT value was 2000 pg/ml (range 58-10 000 pg/ml) in MTC and 2·7 pg/ml (range <2-13 pg/ml) in controls (P < 0·001). Using a cut-off of 39·6 pg/ml, MTC lesions could be identified with 100% sensitivity and specificity. As the most important finding, 14 histologically proved MTC lesions could be detected by FNA-CT, despite they were cytologically diagnosed as benign or nonconclusive.
CONCLUSIONS: This study shows, as the first in a multicentre series, that FNA-CT sensitivity is higher than that of cytology in diagnosing MTC. To avoid false-negative MTC by cytology, CT measurement in aspiration needle washout is to be performed in all patients undergoing biopsy following high serum CT.
© 2013 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23627255     DOI: 10.1111/cen.12234

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  22 in total

Review 1.  Diagnosis and pathologic characteristics of medullary thyroid carcinoma-review of current guidelines.

Authors:  C M Thomas; S L Asa; S Ezzat; A M Sawka; D Goldstein
Journal:  Curr Oncol       Date:  2019-10-01       Impact factor: 3.677

Review 2.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

Review 3.  Calcitonin as a biomarker of C cell disease: recent achievements and current challenges.

Authors:  Giuseppe Costante; Domenico Meringolo
Journal:  Endocrine       Date:  2020-01-10       Impact factor: 3.633

4.  The essential use of FNA-calcitonin for detecting medullary thyroid cancer.

Authors:  P Trimboli; L Guidobaldi; A Crescenzi; M Bongiovanni; L Giovanella
Journal:  Endocrine       Date:  2014-03-08       Impact factor: 3.633

Review 5.  Biologic and Clinical Perspectives on Thyroid Cancer.

Authors:  James A Fagin; Samuel A Wells
Journal:  N Engl J Med       Date:  2016-09-15       Impact factor: 91.245

6.  Neck schwannoma diagnosed by core needle biopsy: a case report.

Authors:  N Nasrollah; P Trimboli; D Bianchi; S Taccogna
Journal:  J Ultrasound       Date:  2014-07-01

7.  Ultrasound features of medullary thyroid carcinoma correlate with cancer aggressiveness: a retrospective multicenter study.

Authors:  Pierpaolo Trimboli; Luca Giovanella; Stefano Valabrega; Massimiliano Andrioli; Roberto Baldelli; Nadia Cremonini; Fabio Rossi; Leo Guidobaldi; Agnese Barnabei; Francesca Rota; Antonella Paoloni; Laura Rizza; Giorgio Fattorini; Maurizio Latini; Claudio Ventura; Paolo Falasca; Fabio Orlandi; Anna Crescenzi; Ferdinando D'Ambrosio; Vito Cantisani; Francesco Romanelli; Roberto Negro; Enrico Saggiorato; Marialuisa Appetecchia
Journal:  J Exp Clin Cancer Res       Date:  2014-10-25

8.  DIAGNOSTIC UTILITY OF HUMAN CHORIONIC GONADOTROPIN WASHOUT IN CERVICAL LYMPH NODE FINE-NEEDLE ASPIRATION FOR METASTATIC TESTICULAR CANCER.

Authors:  Jamie Kaplan; Helmi Khadra; Andrew B Sholl; Emad Kandil
Journal:  AACE Clin Case Rep       Date:  2019-04-25

Review 9.  Medullary Thyroid Cancer - Feature Review and Update on Systemic Treatment.

Authors:  Nina Dabelić; Tomislav Jukić; Ana Fröbe
Journal:  Acta Clin Croat       Date:  2020-06       Impact factor: 0.780

10.  Calcitonin measurement in fine-needle aspirate washouts vs. cytologic examination for diagnosis of primary or metastatic medullary thyroid carcinoma.

Authors:  C de Crea; M Raffaelli; D Maccora; C Carrozza; G Canu; G Fadda; R Bellantone; C P Lombardi
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-12       Impact factor: 2.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.